Walmart offers to pay $3.1B to settle opioid lawsuits
Walmart is the latest company to announce a settlement with local governments over allegations of improperly filling prescriptions for powerful painkillers
Biogen picks new CEO, veteran pharmaceutical leader Christopher Viehbacher
Biopharmaceutical company Biogen has picked a new CEO, former Sanofi CEO Christopher Viehbacher, amid fallout from its failed Alzheimer's drug launch.
Walgreens combines VillageMD and CityMD in $8.9 billion deal
Walgreens will put up $3.5 billion of the $8.9 billion deal to add Summit Health-CityMD to it's primary care portfolio.
App could diagnose Parkinson's, cancer by sound of voice
Dr. Yael Bensoussan of the University of South Florida's Health Voice Center discusses a new technology that could soon diagnose diseases without the hassle of visiting a doctor's office on 'Varney & Co.'
GSK vaccine for older adults granted FDA priority review
GSK reported strong third-quarter earnings and raised its forecast for 2022. However worries about Zantac litigation kept investors on edge.
Pfizer develops RSV vaccine for infants given during pregnancy
Pfizer announced an experimental vaccine that, when administered during pregnancy, would protect infants from severe illness for up to six months of life.
J&J to buy Abiomed in $16.6B deal to boost cardiovascular business
J&J's cardiovascular devices business will benefit from the $16.6 billion deal to acquire Abiomed. The deal comes at a time when J&J is spinning off its consumer health business.
Obamacare open enrollment 2023: What to know
Open enrollment for Affordable Care Act health plans begins Tuesday, and there are a slew of changes to be aware of this year when making a selection.
Amazon has the most abysmal margins of all Big Tech companies: Laura Martin
Needham & Company senior media and internet analyst provides insight on investing in technology stocks on 'Making Money.'
Biotech entrepreneur invests in a ‘new generation’ of cancer, chronic disease treatments
Graviton Biopharmaceutical Holdings Chairman and CEO Sam Waksal discusses growth investment opportunities in biotech and how the sector should be a national priority.
Philips to cut 4K jobs worldwide amid falling sales
Health care technology company Royal Philips NV employs roughly 80,000 employees. Philips chief executive Roy Jakobs called the job cuts "difficult, but necessary."
Tomas Philipson: Health care policy is 'most damaging' issue not discussed by economists
Former Acting Council of Economic Advisers Chair Tomas Philipson and Breitbart economics and finance editor John Carney argue Biden's agenda is shrinking U.S. economic growth.
Pfizer says it's eyeing a $110 to $130 list price for COVID-19 vaccine in U.S.
Pfizer Inc. on Thursday revealed the possible U.S. list price it is eyeing for its adult COVID-19 vaccine doses once the shot hits the commercial market.
Diabetes-related weight loss drugs facing supply issues amid viral trend
Novo Nordisk, which manufactures the antidiabetic drugs Ozempic and Wegovy, told FOX Business it's facing supply issues due to "unprecedented demand" on top of global supply constraints.
German tapped to lead Japan's medical company Olympus as CEO
Known for 35mm film cameras, Olympus now focuses on more advanced cameras, the kinds doctors use to look inside your organs. Foreign CEOs are rare in Japan.
Florida surgeon general: This is the bottom line on COVID-19 booster vaccines
Florida Surgeon General Dr. Joseph Ladapo analyzes Moderna CEO Stephane Bancel's claim that younger individuals might not need annual COVID-19 boosters on 'The Evening Edit.'
FDA authorizes Novavax COVID booster for adults
The Food and Drug Administration authorized the Novavax COVID-19 vaccine as a booster for use in adults on Wednesday. The company has struggled with vaccine sales.
Johnson & Johnson beats sales estimates on pharma strength
The company tightened its full-year adjusted profit forecast range. Sales at its medical devices unit rose to $6.78 billion on demand for contact lenses and wound-closure products.
Walmart, CVS, Walgreens start selling over-the-counter hearing aids: What to know
Retailers started selling over-the-counter hearing aids nationwide this week, giving Americans with perceived mild-to-moderate hearing impairments better access to products.
Elon Musk jumps on new weight-loss trend: diabetic medications
Many people, including buisness magnate Elon Musk, have used a drug known as Wegovy to shed some weight or jumpstart their weight loss. Although it can be pricy.